Press Releases on June 20, 2019 - EIN Presswire - Press Release Distribution Service

Published on June 20, 2019 - 13:10 GMT

UPDATE - Sharps Compliance Releases New Solution Offering for the Safe and Compliant Cleanup of Spilled Hazardous Drugs

HOUSTON, June 20, 2019 (GLOBE NEWSWIRE) -- Sharps Compliance Corp. (Nasdaq: SMED), a nationwide provider of management services for medical, pharmaceutical, and hazardous wastes, has released the Hazardous Drug Spill Control Kit™, a USP <800> …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 20, 2019 - 13:10 GMT

Rosetta Stone and HIAS Partner to Provide Refugee Populations with Language Learning Software

Arlington, VA, June 20, 2019 (GLOBE NEWSWIRE) -- Rosetta Stone and HIAS today announced a new partnership that will make language learning software available to help in the refugee resettlement process and to encourage cross cultural exchanges between …

Distribution channels: Banking, Finance & Investment Industry, IT Industry ...

Published on June 20, 2019 - 13:08 GMT

Autonomous Tractors Market to Grow at a CAGR of 24% from 2018 to 2025

Portland, June 20, 2019 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, Autonomous Tractors Market by Component (Sensor, GPS, Vision System, and Others) and Application (Tillage, Harvesting, Irrigation, Seed Sowing, Spraying, and …

Distribution channels: Banking, Finance & Investment Industry, Book Publishing Industry ...

Published on June 20, 2019 - 13:07 GMT

Jostens Receives 12 Awards at Premier International Print Competition

Minneapolis, June 20, 2019 (GLOBE NEWSWIRE) -- Jostens, the nation’s leading publisher of yearbooks, received a Coveted Best of Category “Benny” Award in the 2019 Premier Print Awards for The United States Naval Academy’s 2018 Lucky Bag Yearbook. Jostens …

Distribution channels: Culture, Society & Lifestyle ...

Published on June 20, 2019 - 13:05 GMT

Automotive High-performance Electric Vehicles Market to Witness a Robust CAGR of 41.67% During 2019-2024

Dublin, June 20, 2019 (GLOBE NEWSWIRE) -- The "Automotive High-performance Electric Vehicles Market: Growth, Trends, and Forecast (2019-2024)" report has been added to ResearchAndMarkets.com's offering. The Automotive High-Performance …

Distribution channels: Banking, Finance & Investment Industry, Technology ...

Published on June 20, 2019 - 13:05 GMT

Phase Genomics Accelerates Microbiome Discovery and Antibiotic Resistance tracking with New ProxiMeta™ 8-Pack Including Bundled ...

SEATTLE, Washington, June 20, 2019 (GLOBE NEWSWIRE) -- Phase Genomics, Inc., the biotech leader providing proximity ligation solutions for genome and metagenome assembly, announces its new ProxiMeta™ Platform, which includes a new 8-pack ProxiMeta Kit …

Distribution channels: Healthcare & Pharmaceuticals Industry ...

Published on June 20, 2019 - 13:05 GMT

Sienna Biopharmaceuticals to Present at BMO Capital Markets Healthcare Conference

WESTLAKE VILLAGE, Calif., June 20, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced that Frederick C. Beddingfield III, M.D., Ph.D., President and Chief Executive Officer of …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...

Published on June 20, 2019 - 13:05 GMT

Elixinol becomes London (UK) Underground’s first Hemp CBD advertiser with a major campaign

Elixinol is driving brand awareness through a high profile digital media campaign and promotion across London’s major rail stations, reaching 2.1m consumers DENVER, June 20, 2019 (GLOBE NEWSWIRE) -- Building on its status as one of the world’s most …

Distribution channels: Conferences & Trade Fairs, Consumer Goods ...

Published on June 20, 2019 - 13:05 GMT

TG Therapeutics Announces Data Presentations at the 15th International Conference on Malignant Lymphoma

Phase 2 study of umbralisib monotherapy in BTK/PI3K-delta Intolerant CLL reports an estimated median progression-free survival (PFS) of 23.5 months (n=50) Phase 1/2 study of U2 + Pembrolizumab reports 83% (5 of 6) ORR in BTK refractory CLL patients, with 4 …

Distribution channels: Conferences & Trade Fairs, Technology ...